2227. Outcomes in Patients with Renal Impairment from a Phase 3 Clinical Trial for Ceftolozane–Tazobactam (C/T) Treatment of Nosocomial Pneumonia (ASPECT-NP). - Huntington, Jennifer A; Yu, Brian; Li, Linping; Jensen, Erin; Bruno, Christopher; Rhee, Elizabeth G (Open Forum Infectious Diseases, 2019)